Literature DB >> 12574290

Rapid detection of rifampin resistance in Mycobacterium tuberculosis isolates by heteroduplex analysis and determination of rifamycin cross-resistance in rifampin-resistant isolates.

Zeynep Saribaş1, Tanil Kocagöz, Alpaslan Alp, Ayfer Günalp.   

Abstract

Direct heteroduplex analysis and a universal heteroduplex generator assay were performed to detect rifampin resistance rapidly in Turkish Mycobacterium tuberculosis isolates. Cross-resistance to rifapentine, rifabutin, and rifalazil was investigated. A relationship between specific mutations and resistance patterns, which can guide the choice of an appropriate therapeutic regimen for tuberculosis patients, was identified.

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 12574290      PMCID： PMC149690          DOI： 10.1128/JCM.41.2.816-818.2003

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN： 0095-1137            Impact factor:   5.948


  11 in total

Review 1.  Molecular genetic basis of antimicrobial agent resistance in Mycobacterium tuberculosis: 1998 update.

Authors:  S Ramaswamy; J M Musser
Journal:  Tuber Lung Dis       Date:  1998

2.  Development of rifapentine susceptibility tests for Mycobacterium tuberculosis.

Authors:  L Heifets; T Sanchez; J Vanderkolk; V Pham
Journal:  Antimicrob Agents Chemother       Date:  1999-01       Impact factor: 5.191

3.  Relationship between antimycobacterial activities of rifampicin, rifabutin and KRM-1648 and rpoB mutations of Mycobacterium tuberculosis.

Authors:  B Yang; H Koga; H Ohno; K Ogawa; M Fukuda; Y Hirakata; S Maesaki; K Tomono; T Tashiro; S Kohno
Journal:  J Antimicrob Chemother       Date:  1998-11       Impact factor: 5.790

4.  Comparative antimycobacterial activities of rifampin, rifapentine, and KRM-1648 against a collection of rifampin-resistant Mycobacterium tuberculosis isolates with known rpoB mutations.

Authors:  S L Moghazeh; X Pan; T Arain; C K Stover; J M Musser; B N Kreiswirth
Journal:  Antimicrob Agents Chemother       Date:  1996-11       Impact factor: 5.191

5.  Genetic screening and testing by induced heteroduplex formation.

Authors:  N Wood; J Bidwell
Journal:  Electrophoresis       Date:  1996-01       Impact factor: 3.535

6.  Detection of rifampicin-resistance mutations in Mycobacterium tuberculosis.

Authors:  A Telenti; P Imboden; F Marchesi; D Lowrie; S Cole; M J Colston; L Matter; K Schopfer; T Bodmer
Journal:  Lancet       Date:  1993-03-13       Impact factor: 79.321

7.  Evaluation of a polymerase chain reaction-based universal heteroduplex generator assay for direct detection of rifampin susceptibility of Mycobacterium tuberculosis from sputum specimens.

Authors:  D L Williams; L Spring; T P Gillis; M Salfinger; D H Persing
Journal:  Clin Infect Dis       Date:  1998-02       Impact factor: 9.079

8.  Detection of Mycobacterium tuberculosis in sputum samples by polymerase chain reaction using a simplified procedure.

Authors:  T Kocagöz; E Yilmaz; S Ozkara; S Kocagöz; M Hayran; M Sachedeva; H F Chambers
Journal:  J Clin Microbiol       Date:  1993-06       Impact factor: 5.948

Review 9.  Current methods of mutation detection.

Authors:  R G Cotton
Journal:  Mutat Res       Date:  1993-01       Impact factor: 2.433

10.  Contribution of rpoB mutations to development of rifamycin cross-resistance in Mycobacterium tuberculosis.

Authors:  D L Williams; L Spring; L Collins; L P Miller; L B Heifets; P R Gangadharam; T P Gillis
Journal:  Antimicrob Agents Chemother       Date:  1998-07       Impact factor: 5.191
View more
  7 in total

1.  Treatment of chronic infections with rifamycins: is resistance likely to follow?

Authors:  Richard E Chaisson
Journal:  Antimicrob Agents Chemother       Date:  2003-10       Impact factor: 5.191

2.  Rapid determination of rifampin resistance in clinical isolates of Mycobacterium tuberculosis by real-time PCR.

Authors:  Tanil Kocagoz; Zeynep Saribas; Alpaslan Alp
Journal:  J Clin Microbiol       Date:  2005-12       Impact factor: 5.948

3.  Sequencing-based detection of low-frequency human immunodeficiency virus type 1 drug-resistant mutants by an RNA/DNA heteroduplex generator-tracking assay.

Authors:  Amit Kapoor; Morris Jones; R W Shafer; Soo-Yon Rhee; Powel Kazanjian; Eric L Delwart
Journal:  J Virol       Date:  2004-07       Impact factor: 5.103

4.  Characterization of Tunisian Mycobacterium tuberculosis rifampin-resistant clinical isolates.

Authors:  Alya Soudani; Sondess Hadjfredj; Mériem Zribi; Afef Masmoudi; Taieb Messaoud; Hanéne Tiouri; Chedlia Fendri
Journal:  J Clin Microbiol       Date:  2007-07-25       Impact factor: 5.948

5.  Molecular characterization of rifampin- and isoniazid-resistant Mycobacterium tuberculosis strains isolated in Poland.

Authors:  Anna Sajduda; Anna Brzostek; Marta Poplawska; Ewa Augustynowicz-Kopec; Zofia Zwolska; Stefan Niemann; Jaroslaw Dziadek; Doris Hillemann
Journal:  J Clin Microbiol       Date:  2004-06       Impact factor: 5.948

6.  Genotyping of Mycobacterium tuberculosis clinical isolates in two cities of Turkey: description of a new family of genotypes that is phylogeographically specific for Asia Minor.

Authors:  Thierry Zozio; Caroline Allix; Selami Gunal; Zeynep Saribas; Alpaslan Alp; Riza Durmaz; Maryse Fauville-Dufaux; Nalin Rastogi; Christophe Sola
Journal:  BMC Microbiol       Date:  2005-07-26       Impact factor: 3.605

Review 7.  Addressing the Challenges of Tuberculosis: A Brief Historical Account.

Authors:  Hussam W Al-Humadi; Rafal J Al-Saigh; Ahmed W Al-Humadi
Journal:  Front Pharmacol       Date:  2017-09-26       Impact factor: 5.810
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.